Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
It was reading about current nuclear discoveries in textbooks that first made Ken Engle want to work at a national lab. It was seeing the real-world impact of the isotopes produced at ORNL
ORNL’s electromagnetic isotope separator, or EMIS, made history in 2018 when it produced 500 milligrams of the rare isotope ruthenium-96, unavailable anywhere else in the world.
Growing up in suburban Upper East Tennessee, Layla Marshall didn’t see a lot of STEM opportunities for children.
“I like encouraging young people to get involved in the kinds of things I’ve been doing in my career,” said Marshall. “I like seeing the students achieve their goals. It’s fun to watch them get excited about learning new things and teaching the robot to do things that they didn’t know it could do until they tried it.”
Marshall herself has a passion for learning new things.
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
A 25-year career with the U.S. Navy, commanding combat missions overseas, brought Tom Kollie back to where he came from — ready to serve his country in a new way.
In the mid-1980s, Balendra Sutharshan moved to Canada from the island nation of Sri Lanka. That move set Sutharshan on a path that had him heading continent-spanning collaborations and holding leadership posts at multiple Department of Energy
For years Brenda Smith found fulfillment working with nuclear batteries, a topic she’s been researching as a chemist at Oak Ridge National Laboratory.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.